Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-06

Clinical Trial Update: Safety and Effect of Doxycycline in Patients With Amyloidosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessed the safety and potential effect of doxycycline in patients with amyloidosis; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Doxycycline (Doxycycline)

Snippet

Sponsor: Boston University | Conditions: Amyloidosis | Phase 2 | Status: COMPLETED | Results posted: 2017-06-06